IGF2BP3 (alias IMP3), represses translation of IGF-2 during late embryonic development in mice and humans [36], and has been shown to promote the translation of IGF-2 leader 3 mRNA in a cell model of leukemia [37]. Here, IGF2BP3 is linked to leukemia.